Trial NCT01892345

View at ClinicalTrials.gov 
Org. Study IDs: ECU-NMO-301

Last trial update was posted on 2019-06-26

MeSH Interventions

Eculizumab

MeSH Conditions

Neuromyelitis Optica

Other Conditions

Neuromyelitis Optica Spectrum Disorder

Stopping Reasons

N/A

Limitations And Caveats

After rigorous review of blinded study data, the Sponsor terminated the study at 23 adjudicated events, not the protocol-specified 24. This was not driven by safety or efficacy concerns, but rather by uncertainty in estimating final event occurrence.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID